Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2023-09-18 00:00:00 ET · period of report 2023-09-11 · accession 0001493152-23-032969 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-18 | 2023-09-11+ | IMMX | Hsu Jason | Dir | P - Purchase | $2.78 | +72.0K | 750.0K | +11% | +$200.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-15 | P | A | 7,000 | $2.49 | 757,000 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $2.59 to $2.42, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2023-09-12 | P | A | 30,000 | $2.83 | 740,000 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $2.91 to $2.70, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-09-11 | P | A | 25,000 | $2.89 | 710,000 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $2.9299 to $2.83, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2023-09-14 | P | A | 10,000 | $2.58 | 750,000 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $2.598 to $2.56, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |